tocilizumab
Selected indexed studies
- Trial of Tocilizumab in Giant-Cell Arteritis. (N Engl J Med, 2017) [PMID:28745999]
- Tocilizumab: A Review in Rheumatoid Arthritis. (Drugs, 2017) [PMID:29094311]
- Tocilizumab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis. (Ann Am Thorac Soc, 2024) [PMID:37773003]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Trial of Tocilizumab in Giant-Cell Arteritis. (2017) pubmed
- Tocilizumab: A Review in Rheumatoid Arthritis. (2017) pubmed
- Tocilizumab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis. (2024) pubmed
- Tocilizumab in transplantation. (2020) pubmed
- Tocilizumab. (2009) pubmed
- Tocilizumab Monotherapy or Combined With Methotrexate for Rheumatoid Arthritis: A Randomized Clinical Trial. (2025) pubmed
- Tocilizumab: From Rheumatic Diseases to COVID-19. (2021) pubmed
- Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. (2016) pubmed
- Tocilizumab for giant cell arteritis. (2022) pubmed
- Tocilizumab and its usage for skin diseases. (2022) pubmed